[HTML][HTML] Buprenorphine implementation at syringe service programs following waiver of the Ryan Haight Act in the United States
BH Lambdin, RN Bluthenthal, HE Tookes… - Drug and alcohol …, 2022 - Elsevier
Introduction Among people with an opioid use disorder in the United States, only 10%
receive buprenorphine treatment. The Ryan Haight Act is a federal law that has regulated …
receive buprenorphine treatment. The Ryan Haight Act is a federal law that has regulated …
[HTML][HTML] Improving equity and access to buprenorphine treatment through telemedicine at syringe services programs
BH Lambdin, D Kan, AH Kral - Substance Abuse Treatment, Prevention …, 2022 - Springer
Background and aims In the United States, access to buprenorphine remains low and
disparities regarding who receives treatment have emerged. Federal laws have regulated …
disparities regarding who receives treatment have emerged. Federal laws have regulated …
Pandemic telehealth flexibilities for buprenorphine treatment: a synthesis of evidence and policy implications for expanding opioid use disorder care in the United …
Buprenorphine is a highly effective treatment for opioid use disorder (OUD) and a critical tool
for addressing the worsening US overdose crisis. However, multiple barriers to treatment …
for addressing the worsening US overdose crisis. However, multiple barriers to treatment …
Comparing telemedicine to in-person buprenorphine treatment in US veterans with opioid use disorder
Background Telemedicine-delivered buprenorphine (tele-buprenorphine) can potentially
increase access to buprenorphine for patients with opioid use disorder (OUD), especially …
increase access to buprenorphine for patients with opioid use disorder (OUD), especially …
'Red flags' and 'red tape': telehealth and pharmacy-level barriers to buprenorphine in the United States
L Textor, D Ventricelli, SV Aronowitz - International Journal of Drug Policy, 2022 - Elsevier
Background Structural vulnerabilities for people who use drugs (PWUD) were exacerbated
by the COVID-19 pandemic. In this context, federal lawmakers in the United States (US) …
by the COVID-19 pandemic. In this context, federal lawmakers in the United States (US) …
Thirty-day treatment continuation after audio-only buprenorphine telehealth initiation
C Wunsch, R Wightman, C Pratty, B Jacka… - Journal of Addiction …, 2023 - journals.lww.com
Objectives Before the coronavirus disease 2019 pandemic, federal law required in-person
evaluation before buprenorphine initiation. Regulatory changes during the pandemic allow …
evaluation before buprenorphine initiation. Regulatory changes during the pandemic allow …
Using telehealth to improve buprenorphine access during and after COVID-19: A rapid response initiative in Rhode Island
SA Clark, C Davis, RS Wightman, C Wunsch… - Journal of substance …, 2021 - Elsevier
Despite its proven efficacy, buprenorphine remains dramatically underutilized for
management of opioid use disorder largely due to onerous barriers to treatment initiation …
management of opioid use disorder largely due to onerous barriers to treatment initiation …
Characteristics and correlates of US clinicians prescribing buprenorphine for opioid use disorder treatment using expanded authorities during the COVID-19 …
CM Jones, MM Diallo, M Vythilingam, JG Schier… - Drug and alcohol …, 2021 - Elsevier
Background To determine how clinicians with a DATA waiver to prescribe buprenorphine for
opioid use disorder (OUD) adapted during the COVID-19 pandemic to emergency …
opioid use disorder (OUD) adapted during the COVID-19 pandemic to emergency …
A telemedicine buprenorphine clinic to serve New York City: Initial evaluation of the NYC public hospital system's initiative to expand treatment access during the …
B Tofighi, J McNeely, D Walzer… - Journal of Addiction …, 2022 - journals.lww.com
Objectives: The purpose of this study was to assess the feasibility and clinical impact of
telemedicine-based opioid treatment with buprenorphine-naloxone following the …
telemedicine-based opioid treatment with buprenorphine-naloxone following the …
Telemedicine increases access to buprenorphine initiation during the COVID-19 pandemic
L Wang, J Weiss, EB Ryan, J Waldman, S Rubin… - Journal of substance …, 2021 - Elsevier
Federal regulatory changes during the COVID-19 pandemic allow buprenorphine to be
prescribed without an initial in-person evaluation. Prior to COVID-19, numerous barriers …
prescribed without an initial in-person evaluation. Prior to COVID-19, numerous barriers …